Ben Arye Barak
SEC insider (Form 3/4/5 filer). CIK 0001917165. General Counsel at NovoCure Ltd (NVCR). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in WAYNE, PA.
Companies Ben Arye Barak has filed insider reports for
- NovoCure Ltd (NVCR): Officer, General Counsel
Ben Arye Barak
CIK: 0001917165
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)7 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVCR
NovoCure Ltd
Officer
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 30, 2026NVCR
NovoCure Ltd
AwardDirect1.3K shares at avg. $11.15$14K - Mar 3, 2026NVCR
NovoCure Ltd
AwardDirect50.1K shares- - Feb 28, 2026NVCR
NovoCure Ltd
AwardDirect17.8K shares- - Dec 31, 2025NVCR
NovoCure Ltd
AwardDirect108 shares at avg. $10.99$1K - Jun 30, 2025NVCR
NovoCure Ltd
AwardDirect769 shares at avg. $15.13$12K - Mar 4, 2025NVCR
NovoCure Ltd
AwardDirect55K shares at avg. $18.19$1000K - Dec 31, 2024NVCR
NovoCure Ltd
AwardDirect669 shares at avg. $14.75$10K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | NVCR NovoCure Ltd | Award | 1,299 | $11.15 | $14,484 | Direct |
| Mar 3, 2026 | NVCR NovoCure Ltd | Award | 50,125 | - | $0 | Direct |
| Feb 28, 2026 | NVCR NovoCure Ltd | Award | 17,755 | - | $0 | Direct |
| Dec 31, 2025 | NVCR NovoCure Ltd | Award | 108 | $10.99 | $1,187 | Direct |
| Jun 30, 2025 | NVCR NovoCure Ltd | Award | 769 | $15.13 | $11,635 | Direct |
| Mar 4, 2025 | NVCR NovoCure Ltd | Award | 54,975 | $18.19 | $999,995 | Direct |
| Dec 31, 2024 | NVCR NovoCure Ltd | Award | 669 | $14.75 | $9,866 | Direct |
1-7 of 7 transactions